1. Rovers MM. The burden of otitis media. Vaccine 2008;26(Suppl 7):G2–G4. PMID:
19094933.
2. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83–94. PMID:
2732519.
3. Shekelle P, Takata G, Chan LS, Mangione-Smith R, Corley PM, Morphew T, et al. Diagnosis, natural history, and late effects of otitis media with effusion. Evid Rep Technol Assess (Summ) 2002;1–5. PMID:
12945555.
4. Casselbrant ML, Mandel EM. In: Flint PW, Haughey BH, Lund VJ, Niparko JK, Richardson MA, Robbins KT. Acute Otitis Media and Otitis Media with Effusion. editors. Cummings Otolaryngology-Head and Neck Surgery. 2010. 5th ed. Philadelphia, PA: Mosby;p.2761–2777.
5. Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO. Costs of otitis media in a managed care population. Pediatr Infect Dis J 2000;19:354–355. PMID:
10783029.
6. Proud GO. Eustachian tube function and middle ear pressures as they influence susceptibility to disease. Laryngoscope 1972;82:1643–1646. PMID:
5079590.
8. Preciado D, Kuo E, Ashktorab S, Manes P, Rose M. Cigarette smoke activates NFκB-mediated Tnf-α release from mouse middle ear cells. Laryngoscope 2010;120:2508–2515. PMID:
21108432.
9. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004;113(4 Suppl):1007–1015. PMID:
15060193.
10. Proud GO, Odoi H. Effects of Eustachian tube ligation. Ann Otol Rhinol Laryngol 1970;79:30–32. PMID:
5415603.
11. Piltcher OB, Swarts JD, Magnuson K, Alper CM, Doyle WJ, Hebda PA. A rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection: methods and disease course. Otolaryngol Head Neck Surg 2002;126:490–498. PMID:
12075222.
12. Aynali G, Yariktaş M, Yasan H, Karahan N, Başpinar S, Tüz M, et al. The effects of methylprednisolone, montelukast and indomethacine in experimental otitis media with effusion. Int J Pediatr Otorhinolaryngol 2011;75:15–19. PMID:
21036406.
13. Russell JD, Giles SJ. Persistent otitis media with effusion: a new experimental model. Laryngoscope 1998;108(8 Pt 1):1181–1184. PMID:
9707240.
14. Huang Q, Zhang Z, Zheng Y, Zheng Q, Chen S, Xu Y, et al. Hypoxia-inducible factor and vascular endothelial growth factor pathway for the study of hypoxia in a new model of otitis media with effusion. Audiol Neurootol 2012;17:349–356. PMID:
22907120.
15. Kerschner JE, Hong W, Taylor SR, Kerschner JA, Khampang P, Wrege KC, et al. A novel model of spontaneous otitis media with effusion (OME) in the Oxgr1 knock-out mouse. Int J Pediatr Otorhinolaryngol 2013;77:79–84. PMID:
23200873.
16. Giebink GS. Otitis media: the chinchilla model. Microb Drug Resist 1999;5:57–72. PMID:
10332723.
17. Jewett BS, Prazma JP, Hunter SE, Rose AS, Clark JM, Sartor BR, et al. Systemic reactivation of otitis media with effusion in a rat model. Otolaryngol Head Neck Surg 1999;121:7–12. PMID:
10388868.
18. Clark JM, Brinson G, Newman MK, Jewett BS, Sartor BR, Prazma J, et al. An animal model for the study of genetic predisposition in the pathogenesis of middle ear inflammation. Laryngoscope 2000;110:1511–1515. PMID:
10983952.
19. Kim HJ, Chole RA. Experimental models of aural cholesteatomas in Mongolian gerbils. Ann Otol Rhinol Laryngol 1998;107:129–134. PMID:
9486907.
20. Wolfman DE, Chole RA. Experimental retraction pocket cholesteatoma. Ann Otol Rhinol Laryngol 1986;95(6 Pt 1):639–644. PMID:
3789599.
21. Yamamoto-Fukuda T, Hishikawa Y, Shibata Y, Kobayashi T, Takahashi H, Koji T. Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils. Am J Pathol 2010;176:2602–2606. PMID:
20413684.
22. Massuda ET, Oliveira JA. A new experimental model of acquired cholesteatoma. Laryngoscope 2005;115:481–485. PMID:
15744162.
23. White SJ, Wright CG, Robinson KS, Meyerhoff WL. Effect of topical hyaluronic acid on experimental cholesteatoma. Am J Otolaryngol 1995;16:312–318. PMID:
7503374.